These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24872082)

  • 41. Role of extracellular vesicles in liver diseases and their therapeutic potential.
    Kostallari E; Valainathan S; Biquard L; Shah VH; Rautou PE
    Adv Drug Deliv Rev; 2021 Aug; 175():113816. PubMed ID: 34087329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver ischemia: apoptosis as a central mechanism of injury.
    Rüdiger HA; Graf R; Clavien PA
    J Invest Surg; 2003; 16(3):149-59. PubMed ID: 12775431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular mechanisms of liver injury: apoptosis or necrosis.
    Wang K
    Exp Toxicol Pathol; 2014 Oct; 66(8):351-6. PubMed ID: 24867271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Use of pentoxyl and methyluracil (methacil) in liver diseases (literature review)].
    Vitlin VI
    Klin Khir (1962); 1971 Mar; 3():71-5. PubMed ID: 4941177
    [No Abstract]   [Full Text] [Related]  

  • 45. Protective and therapeutic possibility of medical herbs for liver cirrhosis.
    Stanković V; Mihailović V; Mitrović S; Jurišić V
    Rom J Morphol Embryol; 2017; 58(3):723-729. PubMed ID: 29250647
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apoptosis and the liver: relevance for the hepato-biliary-pancreatic surgeon.
    Miyoshi H; Gores GJ
    J Hepatobiliary Pancreat Surg; 1998; 5(4):409-15. PubMed ID: 9931390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Chronic liver diseases: what physicians and patients hope for. New strategies against liver cell death].
    Vetter C
    MMW Fortschr Med; 2003 Jun; 145(26):10. PubMed ID: 12916330
    [No Abstract]   [Full Text] [Related]  

  • 48. Apoptosis in selected liver diseases.
    Kiliçarslan A; Kahraman A; Akkiz H; Yildiz Menziletoğlu S; Fingas CD; Gerken G; Canbay A
    Turk J Gastroenterol; 2009 Sep; 20(3):171-9. PubMed ID: 19821198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caspase inhibitors for the treatment of liver disease: friend or foe?
    Woolbright BL; Ding WX; Jaeschke H
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):397-399. PubMed ID: 28276808
    [No Abstract]   [Full Text] [Related]  

  • 50. Malotilate: the new hope for a clinically effective agent for the treatment of liver disease.
    Ryle PR; Dumont JM
    Alcohol Alcohol; 1987; 22(2):121-41. PubMed ID: 3307796
    [No Abstract]   [Full Text] [Related]  

  • 51. Liver cell death: update on apoptosis.
    Bilodeau M
    Can J Gastroenterol; 2003 Aug; 17(8):501-6. PubMed ID: 12945012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [My journey to explore the reproductive medicine for intractable liver disease].
    Okita K
    Nihon Shokakibyo Gakkai Zasshi; 2005 May; 102(5):537-43. PubMed ID: 15920949
    [No Abstract]   [Full Text] [Related]  

  • 53. The significance of apoptosis in the liver.
    Benedetti A; Marucci L
    Liver; 1999 Dec; 19(6):453-63. PubMed ID: 10661678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathophysiological Significance of Hepatic Apoptosis.
    Wang K; Lin B
    ISRN Hepatol; 2013; 2013():740149. PubMed ID: 27335822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sinusoidal communication in liver fibrosis and regeneration.
    Marrone G; Shah VH; Gracia-Sancho J
    J Hepatol; 2016 Sep; 65(3):608-17. PubMed ID: 27151183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-apoptotic therapeutic approaches in liver diseases: do they really make sense?
    Bannert K; Kuhla A; Abshagen K; Vollmar B
    Apoptosis; 2014 Aug; 19(8):1243-53. PubMed ID: 24872082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant human erythropoietin attenuates hepatic injury induced by ischemia/reperfusion in an isolated mouse liver model.
    Hochhauser E; Pappo O; Ribakovsky E; Ravid A; Kurtzwald E; Cheporko Y; Lelchuk S; Ben-Ari Z
    Apoptosis; 2008 Jan; 13(1):77-86. PubMed ID: 18085440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liver.
    Ben-Ari Z; Mor E; Azarov D; Sulkes J; Tor R; Cheporko Y; Hochhauser E; Pappo O
    Apoptosis; 2005 Dec; 10(6):1261-9. PubMed ID: 16215674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-apoptotic pro-survival effect of clotrimazole in a normothermic ischemia reperfusion injury animal model.
    Iannelli A; de Sousa G; Zucchini N; Saint-Paul MC; Gugenheim J; Rahmani R
    J Surg Res; 2011 Nov; 171(1):101-7. PubMed ID: 20605610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blocking the path to death: anti-apoptotic molecules in ischemia/reperfusion injury of the liver.
    Georgiev P; Dahm F; Graf R; Clavien PA
    Curr Pharm Des; 2006; 12(23):2911-21. PubMed ID: 16918421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.